• Title of article

    Aborted myocardial infarction in patients with ST-segment elevation: Insights from the assessment of the safety and efficacy of a new thrombolytic regimen-3 trial electrocardiographic substudy Original Research Article

  • Author/Authors

    Taha Taher، نويسنده , , Yuling Fu، نويسنده , , Galen S Wagner، نويسنده , , Shaun G Goodman، نويسنده , , Claudio Fresco، نويسنده , , Christopher B Granger، نويسنده , , Lars Wallentin، نويسنده , , Frans Van de Werf، نويسنده , , Freek Verheugt، نويسنده , , Paul W Armstrong، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2004
  • Pages
    6
  • From page
    38
  • To page
    43
  • Abstract
    Objectives The investigators undertook a systematic, comprehensive analysis of the therapeutic response and clinical outcomes of reperfusion therapy for acute ST-segment elevation myocardial infarction (STEMI) in 5,470 patients from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 trial. Background Prompt effective reperfusion therapy for acute STEMI may attenuate major myocardial necrosis. Methods We prospectively collected sequential electrocardiographs and clinical data. Aborted myocardial infarction (MI) was defined as maximal creatine kinase ≤2× upper limit of normal coupled with typical evolutionary electrocardiographic changes. Results Of the patients, 727 (13.3%) had an aborted MI, with the highest frequency (25%) occurring in patients treated <1 h after symptom onset. As compared with MI patients, patients with aborted MI more often had complete ST-segment resolution at 60 min (56.3% vs. 30.2%, p < 0.001) and 180 min (61.5% vs. 53%, p < 0.001); they also had smaller infarct sizes based on QRS score at discharge (2.37 vs. 4.62, p <0 .001). Mortality in aborted MI patients compared with those who had true MI was 3.9% versus 4.6% at 30-day and 7.0% versus 7.4% at 1-year. The baseline-adjusted mortality was significantly lower in patients with aborted MI (odds ratio [OR] 0.76, 95% confidence interval [CI] 0.63 to 0.92, p = 0.005 for 30-day and OR 0.70, 95% CI 0.50 to 0.98, p = 0.035 for one year). A very low-risk subset was identified with ≥70% ST-segment resolution at 60 min whose 30-day and 1-year mortality was 1.0% and 2.7%, respectively, compared with 5.9% and 9.3% in aborted MI patients with <70% ST-segment resolution at 60 min (all p ≤ 0.002). Conclusions Prompt fibrinolytic treatment improved the likelihood of aborted MI. The subgroup with complete 60-min ST-segment resolution had the best clinical outcomes.
  • Keywords
    odds ratio , myocardial infarction , PCI , CK-MB , Confidence interval , MI , ECG , OR , Coronary artery bypass graft , Percutaneous coronary intervention , CABG , CI , electrocardiogram/electrocardiographic , STEMI , ST-segment elevation myocardial infarction , creatine kinase-MB fraction , ASSENT-3 , Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 trial
  • Journal title
    JACC (Journal of the American College of Cardiology)
  • Serial Year
    2004
  • Journal title
    JACC (Journal of the American College of Cardiology)
  • Record number

    459220